Heyuan Biotech (688765.SH) released results for the first three quarters, with a net loss of 106 million yuan

Zhitongcaijing · 2d ago

According to Zhitong Finance App News, Heyuan Biotech (688765.SH) disclosed its report for the third quarter of 2026. In the first three quarters, the company achieved operating income of 27.83 million yuan, an increase of 41.55% over the previous year; a net profit loss of 106 million yuan to mother after deducting a loss of 136 million yuan in non-net profit; and basic earnings per share - 0.30 yuan.